Published on in Vol 6, No 8 (2022): August

This is a member publication of University of Oxford (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37821, first published .
Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom

Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom

Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom

Journals

  1. Rudan I, Millington T, Antal K, Grange Z, Fenton L, Sullivan C, Buelo A, Wood R, Woolford L, Swann O, Murray J, Cullen L, Moore E, Haider F, Almaghrabi F, McMenamin J, Agrawal U, Shah S, Kerr S, Simpson C, Katikireddi S, Ritchie S, Robertson C, Sheikh S. BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland. The Lancet Regional Health - Europe 2022;23:100513 View
  2. Oja M, Tamm S, Mooses K, Pajusalu M, Talvik H, Ott A, Laht M, Malk M, Lõo M, Holm J, Haug M, Šuvalov H, Särg D, Vilo J, Laur S, Kolde R, Reisberg S. Transforming Estonian health data to the Observational Medical Outcomes Partnership (OMOP) Common Data Model: lessons learned. JAMIA Open 2023;6(4) View
  3. Fruchart M, Quindroit P, Jacquemont C, Beuscart J, Calafiore M, Lamer A. Transforming Primary Care Data Into the Observational Medical Outcomes Partnership Common Data Model: Development and Usability Study. JMIR Medical Informatics 2024;12:e49542 View